TrialInvestigational new drugs2014

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients.

Douglas A Rubinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.